| [The clinical value of mdm-2 (proto-oncogene) expression in testicular cancer, Correlation with tumor progression]. | testicular, |
| Oncoprotein MDM2 overexpression is associated with poor prognosis in distinct non-Hodgkin s lymphoma entities. | lymphoma, |
| The MDM2 oncoprotein promotes apoptosis in p53-deficient human medullary thyroid carcinoma cells. | thyroid, |
| Incidence and prognostic significance of MDM2 oncoprotein overexpression in relapsed childhood acute lymphoblastic leukemia. | leukemia, |
| Colony formation of soft tissue sarcoma cells is inhibited by lipid-mediated antisense oligodeoxynucleotides targeting the human mdm2 oncogene. | sarcoma,colorectal, |
| Absence of mutations in the functional domains of the human MDM2 oncogene in non-small cell lung carcinomas. | lung, |
| Alternative and aberrant messenger RNA splicing of the mdm2 oncogene in invasive breast cancer. | breast, |
| Interaction between gene p53 and oncogene mdm2 in human glandular lung cancer cell line GLC-82. | lung, |
| High levels of the MDM2 oncogene in paediatric rhabdomyosarcoma cell lines may confer multidrug resistance. | sarcoma,pediatric, |
| Overexpression of MDM2 oncoprotein correlates with possession of estrogen receptor alpha and lack of MDM2 mRNA splice variants in human breast cancer. | breast, |
| The mdm2 proto-oncogene sensitizes human medullary thyroid carcinoma cells to ionizing radiation. | thyroid, |
| Possible Relation of p53 and mdm-2 Oncoprotein Expression in Thyroid Carcinoma: A Molecular-Pathological and Immunohistochemical Study on Paraffin-Embedded Tissue. | thyroid, |
| Antisense therapy targeting MDM2 oncogene in prostate cancer: Effects on proliferation, apoptosis, multiple gene expression, and chemotherapy. | prostate, |
| The central acidic domain of MDM2 is critical in inhibition of retinoblastoma-mediated suppression of E2F and cell growth. | retinoblastoma, |
| [Preliminary study on oncogene MDM2 in acute leukemias]. | leukemia, |
| [Relationship between the expression of murine double minute 2 oncogene and non-Hodgkin lymphoma in childhood]. | lymphoma, |
| Immunohistochemically detectable p53 and mdm-2 oncoprotein expression in colorectal carcinoma: prognostic significance. | colorectal, |
| Regulation of angiogenic factors by HDM2 in renal cell carcinoma. | kidney, |
| Elevated levels of oncogenic protein kinase Pim-1 induce the p53 pathway in cultured cells and correlate with increased Mdm2 in mantle cell lymphoma. | lymphoma, |
| Enhanced MDM2 Oncoprotein Expression in Soft Tissue Sarcoma: Several Possible Regulatory Mechanisms. | sarcoma, |